-- Hubei Jumpcan Pharmaceutical's (SHA:600566) Jianwei Xiaoshi Oral Liquid was selected for the National Chinese Patent Medicine's centralized procurement, according to a Friday disclosure to the Shanghai bourse.
The drug is used to treat food stagnation and indigestion.
During the procurement period, medical institutions will prioritize the use of the selected products, the pharmaceutical company said.